Eprazin en es it fr

Eprazin Brand names, Eprazin Analogs

Eprazin Brand Names Mixture

  • No information avaliable

Eprazin Chemical_Formula


Eprazin RX_link


Eprazin fda sheet

Eprazin FDA

Eprazin msds (material safety sheet)

Eprazin MSDS

Eprazin Synthesis Reference

No information avaliable

Eprazin Molecular Weight

785.879 g/mol

Eprazin Melting Point

No information avaliable

Eprazin H2O Solubility

No information avaliable

Eprazin State

No information avaliable

Eprazin LogP


Eprazin Dosage Forms

No information avaliable

Eprazin Indication

For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.

Eprazin Pharmacology

Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.

Eprazin Absorption

Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.

Eprazin side effects and Toxicity

LD50 > 2 g/kg (orally, in rats)

Eprazin Patient Information

No information avaliable

Eprazin Organisms Affected

Enteric bacteria and eubacteria